1. Home
  2. RGP vs CLNN Comparison

RGP vs CLNN Comparison

Compare RGP & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Resources Connection Inc.

RGP

Resources Connection Inc.

HOLD

Current Price

$4.83

Market Cap

146.3M

ML Signal

HOLD

Logo Clene Inc.

CLNN

Clene Inc.

HOLD

Current Price

$6.30

Market Cap

120.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGP
CLNN
Founded
1996
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
146.3M
120.6M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
RGP
CLNN
Price
$4.83
$6.30
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$6.00
$32.67
AVG Volume (30 Days)
349.9K
283.4K
Earning Date
01-02-2026
11-13-2025
Dividend Yield
5.75%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$534,625,000.00
$214,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.75
$87.58
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.13
$2.28
52 Week High
$9.96
$13.50

Technical Indicators

Market Signals
Indicator
RGP
CLNN
Relative Strength Index (RSI) 55.71 34.10
Support Level $4.71 $8.90
Resistance Level $4.89 $9.92
Average True Range (ATR) 0.20 1.14
MACD 0.02 -0.27
Stochastic Oscillator 81.48 3.81

Price Performance

Historical Comparison
RGP
CLNN

About RGP Resources Connection Inc.

Resources Connection Inc provides consulting and business initiative support services predominantly through its operative subsidiary, Resources Global Professionals. It has two segments RGP ( Resources Global Professionals.) and Sitrick. The RGP segment is focused on delivering consulting services catering to its client's operational needs and change initiatives utilizing a combination of bench and on-demand, talent. The Sitrick segment provides corporate, financial, transactional, and crisis communication and management services. The company generates a majority of its revenue from the RGP segment. Geographically, it derives its key revenue from North America and the rest from Europe and the Asia Pacific region.

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Share on Social Networks: